Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Regulatory status : IV infusions of products containing NAD+ are not approved by the Therapeutic Goods Administration (TGA) because they have not been assessed for safety, quality or efficacy
Jumping to the maintenance dose immediately leads to significant gastrointestinal side effects that can derail an entire protocol
Its classified as a performance-enhancing substance, so it could have implications if youre in competitive athletics
The safest approach
Several factors influence how quickly you might respond to treatment
US$ 27.13
US$ 24.88
US$ 24.27
US$ 21.76
US$ 29.06
US$ 24.92
US$ 24.65
US$ 25.19
US$ 27.73
